title: Sorafenib (Nexavar) for thyroid cancer.
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D003873:Dermatitis, Exfoliative / Q000139:chemically induced / Q000175:diagnosis; D006801:Humans; D009536:Niacinamide / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D010671:Phenylurea Compounds / Q000009:adverse effects / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic / Q000639:trends; D000077157:Sorafenib; D013964:Thyroid Neoplasms / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology
chemical_list: D000970:Antineoplastic Agents; D010671:Phenylurea Compounds; D009536:Niacinamide; D000077157:Sorafenib